ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical Trial

NCT06213727 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Corneal Epithelial Defect

Interventions

DRUG: lowe-dose ZKY001 eye drops
DRUG: Medium-dose ZKY001 eye drops
DRUG: ZKY001 simulated eye drops

Sponsor

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.